Thorne HealthTech, which develops innovative solutions for a personalized approach to health and wellbeing, closed its IPO of 7 million shares at $10 per share. The stock trades on the Nasdaq under THRN.
BofA Securities, Cowen and Evercore ISI were lead book-running managers for the offering. RBC Capital Markets acted as an additional book-running manager. Read more.
